S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Standard BioTools Inc.

LAB Healthcare
$1.12 +$0.01 (0.90%)
Market Cap: $430.71 M
Gurus Holding
4
Popularity Rank
#2229
% of Shares Held
16.93%
Net Activity (Q4 2025)
+$160,956.16

Guru Ownership Trend

Guru Analysis for Standard BioTools Inc. (LAB)

Standard BioTools Inc. (LAB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $72.9 M.

Top institutional holders include Andreas Halvorsen and Catherine Wood.

Institutional sentiment is currently Bullish. This is evidenced by a $160,956.16 net inflow during the quarter.

Recent activity highlights Chuck Royce who increased their stake by 2.9%. Conversely, Cliff Asness reduced exposure by 20.3%.

Key Holders

Top 5 by Value

$3.93 M
$3.69 M
$634,529

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$160,956.16
Total Buy Value
New Buys 0
Additions 2
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
2

FAQs for Standard BioTools Inc. (LAB)

Major holders include Andreas Halvorsen ($76.25 M), Catherine Wood ($3.93 M), Chuck Royce ($3.69 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 65.09 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $160,956.16, with 2 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in LAB during the most recent reporting period.

Yes, 0 managers opened new positions in LAB, and 2 increased their existing holdings. The total reported buy value was $160,956.16.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.20% 58,651,170 $76.25 M Q3 2025
0.03% Add 1.5% 3,066,665 $3.93 M Q4 2025
0.04% Add 2.9% 2,885,529 $3.69 M Q4 2025
0.00% Reduce -20.3% 488,099 $634,529 Q3 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form